- JNJ -2.48%
Search results
- 149.70Add to watchlist-3.80 (-2.48%)At close: Thu. May 23, 2024 4:00 PM EDT · Delayed Quote (USD) · Market closed
- Open152.75High152.84Low149.38
- Mkt Cap360.28BP/E (TTM)22.21Div & Yield4.96 & 3.31%
- Prev. Close153.5052 Wk. Low143.1352 Wk. High175.97
What analysts are sayingTop storiesJohnson & Johnson's Dividend AnalysisYahoo Finance · 4 days ago- JNJ -2.48%
Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling CautionYahoo Finance · 6 days ago- JNJ -2.48%
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance · 1 week agoRelated stocks
Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Discover J&J. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Sep 23, 2020 · A fourth Covid-19 vaccine candidate has gone into the final stage of clinical trials in the U.S., with Johnson & Johnson announcing the start of its Phase 3 trial Wednesday.
CORONAVIRUS. The Johnson & Johnson vaccine is based on the virus’s genetic instructions for building the spike protein. But unlike the Pfizer-BioNTech and Moderna vaccines, which store the ...
Learn how we're tackling the world's toughest health challenges. Working with Johnson & Johnson can change everything—including you. Explore impactful jobs, inclusive employee benefits and how you can join us.
Apr 13, 2021 · As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a...
Mar 4, 2021 · What's more, the Johnson & Johnson vaccine's effectiveness against severe disease was found to increase over time — to more than 90 percent within a month and a half after vaccination.